Jaime Modiano

Founder at ApopLogic Pharmaceuticals, Inc.

Consumer Services

Health Technology

Profile

Jaime F.
Modiano is the founder of ApopLogic Pharmaceuticals, Inc., which was founded in 2006.
He held the title of Scientist at the company.
Dr. Modiano's former job positions include being an Assistant Professor at Texas A&M University from 1995 to 1999, an Associate Professor at the University of Colorado Health Sciences Center in 2007, and a Senior Scientist at AMC Cancer Research Center.
Dr. Modiano's education history includes earning a doctorate degree from the University of Pennsylvania in 1991 and an undergraduate degree from El Colegio de México AC in 1981.

Jaime Modiano active positions

Companies	Position	Start
ApopLogic Pharmaceuticals, Inc. ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO.	Founder	31/07/2006

All active positions of Jaime Modiano

Former positions of Jaime Modiano

Companies	Position	End
University of Colorado Health Sciences Center	Corporate Officer/Principal	31/12/2006
Texas A&M University	Corporate Officer/Principal	31/12/1998
AMC Cancer Research Center	Corporate Officer/Principal	-

See the detail of Jaime Modiano's experience

Training of Jaime Modiano

University of Pennsylvania	Doctorate Degree
El Colegio de México AC	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jaime Modiano's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
ApopLogic Pharmaceuticals, Inc. ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO.	Health Technology
AMC Cancer Research Center